ENDRA Life Sciences (NDRA) Competitors $4.79 -0.01 (-0.21%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$4.74 -0.05 (-1.04%) As of 09/19/2025 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. OSRH, FEMY, CODX, MHUA, DHAI, XAIR, LYRA, STSS, TNON, and POAIShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include OSR (OSRH), Femasys (FEMY), Co-Diagnostics (CODX), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Beyond Air (XAIR), Lyra Therapeutics (LYRA), Sharps Technology (STSS), Tenon Medical (TNON), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Its Competitors OSR Femasys Co-Diagnostics Meihua International Medical Technologies DIH Holding US Beyond Air Lyra Therapeutics Sharps Technology Tenon Medical Predictive Oncology ENDRA Life Sciences (NASDAQ:NDRA) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Do analysts rate NDRA or OSRH? ENDRA Life Sciences presently has a consensus target price of $50.00, indicating a potential upside of 943.84%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe ENDRA Life Sciences is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NDRA or OSRH more profitable? OSR's return on equity of -12.19% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -194.14% -127.89% OSR N/A -12.19%-8.18% Which has more volatility and risk, NDRA or OSRH? ENDRA Life Sciences has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500. Comparatively, OSR has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Do insiders & institutionals believe in NDRA or OSRH? 1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 60.6% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation and earnings, NDRA or OSRH? OSR has higher revenue and earnings than ENDRA Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$11.51M-$33.89-0.14OSR$104.74K155.89-$2.41MN/AN/A Does the media refer more to NDRA or OSRH? In the previous week, ENDRA Life Sciences' average media sentiment score of 0.00 equaled OSR'saverage media sentiment score. Company Overall Sentiment ENDRA Life Sciences Neutral OSR Neutral SummaryOSR beats ENDRA Life Sciences on 7 of the 10 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NDRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.61M$6.76B$5.77B$10.45BDividend YieldN/A1.21%5.61%4.57%P/E Ratio-0.1426.7880.5026.82Price / SalesN/A195.17456.1891.69Price / CashN/A21.7437.6661.43Price / Book1.004.9815.756.39Net Income-$11.51M$178.07M$3.30B$271.80M7 Day Performance1.05%5.36%5.35%3.51%1 Month Performance5.51%11.09%7.28%9.58%1 Year Performance-30.53%18.41%80.79%28.53% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences1.7342 of 5 stars$4.79-0.2%$50.00+943.8%-30.5%$3.61MN/A-0.1420Short Interest ↓OSRHOSRN/A$0.55-3.6%N/AN/A$12.41MN/A0.00N/AGap UpFEMYFemasys2.5015 of 5 stars$0.38+2.4%$7.33+1,805.3%-69.6%$12.24M$1.63M-0.4530High Trading VolumeCODXCo-Diagnostics3.77 of 5 stars$0.31+0.2%$5.50+1,671.9%-66.1%$11.94M$3.91M-0.27100News CoverageAnalyst ForecastGap UpMHUAMeihua International Medical Technologies1.458 of 5 stars$0.38+2.2%N/A-60.6%$11.81M$96.90M0.00620News CoveragePositive NewsShort Interest ↓DHAIDIH Holding US0.0676 of 5 stars$0.22-8.9%N/A-90.3%$11.59M$64.47M-0.74N/ANews CoverageGap DownXAIRBeyond Air4.4418 of 5 stars$3.31+49.8%$11.00+232.3%-72.1%$11.55M$3.70M-0.2870Short Interest ↓Gap UpHigh Trading VolumeLYRALyra Therapeutics2.6941 of 5 stars$6.60-3.6%$100.00+1,415.2%-55.0%$11.27M$1.53M-0.2350Gap UpHigh Trading VolumeSTSSSharps Technology0.6026 of 5 stars$10.24-4.7%N/AN/A$10.99MN/A-0.013TNONTenon Medical1.3243 of 5 stars$1.17-0.8%$5.50+370.1%-77.0%$10.48M$3.28M-0.048News CoverageGap DownPOAIPredictive Oncology0.5097 of 5 stars$0.96+6.3%N/A+23.7%$9.85M$1.62M-0.3230News CoverageGap Up Related Companies and Tools Related Companies OSR Competitors Femasys Competitors Co-Diagnostics Competitors Meihua International Medical Technologies Competitors DIH Holding US Competitors Beyond Air Competitors Lyra Therapeutics Competitors Sharps Technology Competitors Tenon Medical Competitors Predictive Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NDRA Stock Alerts